- Record: found
- Abstract: not found
- Conference Proceedings: not found
The Addition of Navitoclax to Ruxolitinib Demonstrates Efficacy within Different High-Risk Populations in Patients with Relapsed/Refractory Myelofibrosis
N Pemmaraju, J garcía, J Potluri, L. Holes, J Harb, P. Jung, J. Hutti, J Prchal, S Verstovsek, C. HARRISON
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.